Curing Hepatitis C in People Living with HIV

Participants of this webinar will be able to:

  • Identify how to diagnose and assess hepatitis C among people living with HIV;
  • Learn how to access hepatitis C treatment in British Columbia;
  • Choose the right regimen for hepatitis C cure; and
  • Understand options and timelines for individually tailored courses of treatment.

SPEAKERS:
Mark Hull, MD, MHSc, FRCPC
Research Scientist
BC Centre for Excellence in HIV/AIDS
Clinical Associate Professor
University of British Columbia
Department of Medicine
Division of Infectious Diseases
St. Paul’s Hospital, Providence Health Care

Hesham Ali
Peer Navigator
Positive Living Society of British Columbia


Cost: Free registration.

The recorded session will be accessible on the BC-CfE’s website at education.cfenet.ubc.ca/webinars.

The HIV/AIDS Webinar Learning Series The HIV/AIDS Webinar Learning Series is a partnership between the BC Centre for Excellence in HIV/AIDS (BC-CfE) and Positive Living BC. The goal of the Series is to empower people living with HIV and to improve their quality of life by providing them and health care providers with up-to-date treatment information related to HIV/AIDS. Sessions bring together experts to share their knowledge and provide a forum for interaction, dialogue and mutual learning.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below